載入...
2462. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Individuals 56 Years of Age and Older
BACKGROUND: The MenACYW-TT conjugate vaccine is a quadrivalent meningococcal vaccine candidate intended for global use in all age groups. This Phase III study evaluated the safety and immunogenicity of the vaccine when compared with a licensed quadrivalent meningococcal polysaccharide vaccine (MPSV4...
Na minha lista:
| 發表在: | Open Forum Infect Dis |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6255455/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.2115 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|